Legend Biotech Corporation

04/30/2021 | Press release | Distributed by Public on 04/30/2021 04:43

Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed[...]